Skip to main content
SpringerLink
Log in
Book cover

The Microbiome in Rheumatic Diseases and Infection pp 403–408Cite as

Chronic Recurrent Multifocal Osteomyelitis (CRMO)

  • Chapter
  • First Online:

  • 1007 Accesses

Abstract

Chronic recurrent multifocal osteomyelitis is an autoinflammatory disease that has a genetic component to disease susceptibility. It is a painful disease in which osteomyelitis occurs in one or more sites. Cultures are sterile and there is typically no improvement with antibiotics. It is associated with a personal or family history of inflammatory disease of the intestine, joints, or skin, most commonly psoriasis or Crohn’s disease. Adults can develop sterile osteomyelitis as part of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. CRMO can occur as part of a Mendelian syndrome; however, the vast majority of cases of CRMO and SAPHO syndrome are non-syndromic. Four genes have been identified that when mutated can cause sterile bone inflammation. Mutations in LPIN2, IL1RN, and FBLIM1 have been identified in humans with CRMO and Pstpip2 in a murine model of CRMO. The inflammatory bone disease in the chronic multifocal osteomyelitis (cmo) mouse is IL-1β dependent and neutrophil driven. Syndromic forms of human CRMO are also IL-1 driven, but the role of IL-1 in non-syndromic cases is not clear. Diet-driven changes in the microbiome may play a key role in disease development in murine cmo, as a high-fat diet is associated with dysbiosis and prevents disease manifestations. Fecal transplants from high-fat diet-fed cmo mice can modulate the cmo phenotype. Neutrophils from the mice fed a high-fat diet produced less IL-1β again supporting the role of the neutrophil in cmo disease pathogenesis. The role of the microbiota in human CRMO and SAPHO syndrome is unknown.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

CMO:

Chronic multifocal osteomyelitis

CNO:

Chronic nonbacterial osteomyelitis

DIRA:

Deficiency of the IL-1 receptor antagonist

HFD:

High-fat diet

LFD:

Low-fat diet

LPS:

Lipopolysaccharide

NBO:

Nonbacterial osteomyelitis

NLRP3:

Nlr family pyrin domain containing 3

NSAID:

Nonsteroidal anti-inflammatory drug

PSTPIP2:

Proline-serine-threonine phosphatase-interacting protein 2

SAPHO:

Synovitis, acne, pustulosis, hyperostosis, osteitis

WB-MRI:

Whole-body magnetic resonance imaging

References

  1. Jansson A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154–60.

    Article  CAS  Google Scholar 

  2. Giedion A, et al. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol (Paris). 1972;15(3):329–42.

    CAS  Google Scholar 

  3. Probst FP, Bjorksten B, Gustavson KH. Radiological aspect of chronic recurrent multifocal osteomyelitis. Ann Radiol (Paris). 1978;21(2–3):115–25.

    CAS  Google Scholar 

  4. Girschick HJ, et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64(2):279–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chamot AM, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;54(3):187–96.

    PubMed  CAS  Google Scholar 

  6. Jansson AF, Grote V, E.S. Group. Nonbacterial osteitis in children: data of a German incidence surveillance study. Acta Paediatr. 2011;100(8):1150–7.

    Article  PubMed  Google Scholar 

  7. Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine. 2001;68(3):245–51.

    Article  CAS  PubMed  Google Scholar 

  8. Schultz C, et al. Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J. 1999;18(11):1008–13.

    Article  CAS  PubMed  Google Scholar 

  9. Huber AM, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141(2):198–203.

    Article  PubMed  Google Scholar 

  10. Wipff J, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67(4):1128–37.

    Article  CAS  PubMed  Google Scholar 

  11. Hedrich CM, et al. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47.

    Article  PubMed  PubMed Central  Google Scholar 

  12. El-Shanti HI, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res. 2007;462:11–9.

    Article  PubMed  Google Scholar 

  13. Morbach H, et al. Autoinflammatory bone disorders. Clin Immunol. 2013;147(3):185–96.

    Article  CAS  PubMed  Google Scholar 

  14. Toussirot E, Dupond JL, Wendling D. Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis. 1997;56(1):52–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sonozaki H, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis. 1981;40(6):547–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Maugars Y, et al. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol. 1995;22(11):2135–41.

    PubMed  CAS  Google Scholar 

  17. Vittecoq O, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43(1):109–19.

    Article  CAS  PubMed  Google Scholar 

  18. Boutin RD, Resnick D. The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol. 1998;170(3):585–91.

    Article  CAS  PubMed  Google Scholar 

  19. Kahn MF. Why the “SAPHO” syndrome? J Rheumatol. 1995;22:2017–9.

    PubMed  CAS  Google Scholar 

  20. Jurik AG. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol. 2004;8(3):243–53.

    Article  PubMed  Google Scholar 

  21. Bousvaros A, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44(12):2500–7.

    Article  CAS  PubMed  Google Scholar 

  22. Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol. 2007;19(5):492–8.

    Article  CAS  PubMed  Google Scholar 

  23. Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29(4):1159–77.

    Article  PubMed  Google Scholar 

  24. Khanna L, El-Khoury GY. SAPHO syndrome—a pictorial assay. Iowa Orthop J. 2012;32:189–95.

    PubMed  PubMed Central  Google Scholar 

  25. Guerin-Pfyffer S, et al. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine. 2012;79(6):616–20.

    Article  PubMed  Google Scholar 

  26. Mandell GA, et al. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39(10):1778–83.

    PubMed  CAS  Google Scholar 

  27. Fritz J. The contributions of whole-body magnetic resonance imaging for the diagnosis and management of chronic recurrent multifocal osteomyelitis. J Rheumatol. 2015;42(8):1359–60.

    Article  CAS  PubMed  Google Scholar 

  28. Kennedy MT, et al. Whole body MRI in the diagnosis of chronic recurrent multifocal osteomyelitis. Orthop Traumatol Surg Res. 2012;98(4):461–4.

    Article  CAS  PubMed  Google Scholar 

  29. Bjorksten B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br. 1980;62(3):376–80.

    Article  Google Scholar 

  30. Girschick HJ, et al. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum Pathol. 1999;30(1):59–65.

    Article  CAS  PubMed  Google Scholar 

  31. Sharma M, Ferguson PJ. Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol. 2013;25(5):658–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol. 2000;59(5):352–3.

    Article  CAS  PubMed  Google Scholar 

  33. Beck C, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12(2):R74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhao Y, et al. Physicians’ perspectives on the diagnosis and treatment of chronic nonbacterial osteomyelitis. Int J Rheumatol. 2017;2017:7694942.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Zhao Y, Laxer RM, Ferguson PJ. Treatment advances in chronic non-bacterial osteomyelitis and other autoinflammatory bone conditions. Curr Treat Options Rheum. 2017;3(1):17–32.

    Article  Google Scholar 

  36. Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14(2):130–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Eleftheriou D, et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology. 2010;49(8):1505–12.

    Article  CAS  PubMed  Google Scholar 

  38. Roderick M, et al. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford). 2014;53(11):1973–6.

    Article  CAS  Google Scholar 

  39. Hofmann SR, et al. Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol. 2016;43(11):​1956–64.

    Article  CAS  PubMed  Google Scholar 

  40. Hofmann C, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol. 2014;32(4):604–9.

    PubMed  Google Scholar 

  41. Park H, et al. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol. 2012;12(8):570–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Aksentijevich I, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360(23):2426–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Reddy S, et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009;360(23):2438–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Jesus AA, et al. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Arthritis Rheum. 2011;63(12):4007–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Minkis K, et al. Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Arch Dermatol. 2012;148(6):747–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med. 2014;65:223–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ferguson PJ, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42(7):551–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Majeed HA, et al. The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr. 2001;160(12):705–10.

    Article  CAS  PubMed  Google Scholar 

  49. Rao AP, et al. Phenotypic variability in Majeed syndrome. J Rheumatol. 2016;43(6):1258–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Herlin T, et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis. 2013;72(3):410–3.

    Article  CAS  PubMed  Google Scholar 

  51. Lorden G, et al. Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J Exp Med. 2016;214(2):511–28.

    Article  CAS  PubMed  Google Scholar 

  52. Cox AJ, Darbro BW, Laxer RM, Velez G, Bing X, Finer AL, Erives A, Mahajan VB, Bassuk AG, Ferguson PJ. Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017;12(3):e0169687.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Golla A, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10(3):217–21.

    Article  PubMed  Google Scholar 

  54. Hofmann SR, et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol. 2011;141(3):317–27.

    Article  CAS  PubMed  Google Scholar 

  55. Hofmann SR, et al. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int J Rheumatol. 2012;2012:310206.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Ferguson PJ, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38(1):41–7.

    Article  CAS  PubMed  Google Scholar 

  57. Grosse J, et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood. 2006;107(8):3350–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Liao HJ, et al. Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford). 2015;54(7):1317–26.

    Article  CAS  Google Scholar 

  59. Byrd L, et al. Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. Genomics. 1991;11(4):794–8.

    Article  CAS  PubMed  Google Scholar 

  60. Chitu V, et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood. 2009;114(12):2497–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Cassel SL, et al. Inflammasome-independent IL-1beta mediates autoinflammatory disease in Pstpip2-deficient mice. Proc Natl Acad Sci U S A. 2014;111(3):1072–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lukens JR, et al. Critical role for inflammasome-independent IL-1beta production in osteomyelitis. Proc Natl Acad Sci U S A. 2014;111(3):1066–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Lukens JR, et al. Dietary modulation of the microbiota affects autoinflammatory disease. Nature. 2014;516(7530):246–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Xiao G, et al. Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. J Biol Chem. 2012;287(25):21450–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Hutchins AP, Poulain S, Miranda-Saavedra D. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood. 2012;119(13):e110–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Iowa Carver College of Medicine, Iowa City, IA, USA

    Polly J. Ferguson

Authors
  1. Polly J. Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Polly J. Ferguson .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Cairo University, Cairo, Egypt

    Gaafar Ragab

  2. University of Alabama, Birmingham, Alabama, USA

    T. Prescott Atkinson

  3. University of Alabama, Birmingham, Alabama, USA

    Matthew L. Stoll

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ferguson, P.J. (2018). Chronic Recurrent Multifocal Osteomyelitis (CRMO). In: Ragab, G., Atkinson, T., Stoll, M. (eds) The Microbiome in Rheumatic Diseases and Infection. Springer, Cham. https://doi.org/10.1007/978-3-319-79026-8_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-79026-8_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-79025-1

  • Online ISBN: 978-3-319-79026-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation